A Study of HS-20106 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes

Clinical trial NCT06594965 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06594965
Sponsor: Hansoh BioMedical R&D Company
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Anemia MDS Bone Marrow Disease

Start date: 2024-10-30
Primary completion: 2025-10-30
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.